Long covid-mechanisms, risk factors, and management
- PMID: 34312178
- DOI: 10.1136/bmj.n1648
Long covid-mechanisms, risk factors, and management
Erratum in
-
Correction.BMJ. 2021 Aug 3;374:n1944. doi: 10.1136/bmj.n1944. BMJ. 2021. PMID: 34344715 No abstract available.
Abstract
Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on the lives and health of people around the globe. As of 4 July 2021, more than 183 million confirmed cases of covid-19 had been recorded worldwide, and 3.97 million deaths. Recent evidence has shown that a range of persistent symptoms can remain long after the acute SARS-CoV-2 infection, and this condition is now coined long covid by recognized research institutes. Studies have shown that long covid can affect the whole spectrum of people with covid-19, from those with very mild acute disease to the most severe forms. Like acute covid-19, long covid can involve multiple organs and can affect many systems including, but not limited to, the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. The symptoms of long covid include fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of post-traumatic stress disorder, muscle pain, concentration problems, and headache. This review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure. Risk factors for acute covid-19 and long covid and possible therapeutic options are also discussed.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: We have read and understood the BMJ policy on declaration of interests and declare the following interests: PE was funded by the Medical Research Council and now by Higher Education Funding Council for England (HEFCE). He has also received grants from Alzheimer’s Research, UK, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Society, UK, Medical Research Council, Alzheimer’s Association US, Van-Geest foundation, and European Union grants. PE is a consultant to Roche, Pfizer, and Novo Nordisk. He has received educational and research grants from GE Healthcare, Novo Nordisk, Piramal Life Science/Life Molecular Imaging, Avid Radiopharmaceuticals and Eli Lilly. He is a member of the Scientific Advisory Board at Novo Nordisk.
Similar articles
-
[Long COVID: nosographic aspects and clinical epidemiology].G Ital Cardiol (Rome). 2022 Sep;23(9):651-662. doi: 10.1714/3860.38447. G Ital Cardiol (Rome). 2022. PMID: 36039714 Review. Italian.
-
The Pathophysiology of Long COVID throughout the Renin-Angiotensin System.Molecules. 2022 May 2;27(9):2903. doi: 10.3390/molecules27092903. Molecules. 2022. PMID: 35566253 Free PMC article. Review.
-
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.PLoS Med. 2021 Sep 28;18(9):e1003773. doi: 10.1371/journal.pmed.1003773. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34582441 Free PMC article.
-
Post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'.Cleve Clin J Med. 2021 May 3;88(5):267-272. doi: 10.3949/ccjm.88a.21010. Cleve Clin J Med. 2021. PMID: 33941600
-
Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.Rev Neurol. 2021 Jun 1;72(11):384-396. doi: 10.33588/rn.7211.2021230. Rev Neurol. 2021. PMID: 34042167 Review. English, Spanish.
Cited by
-
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.Neurosci Behav Physiol. 2022;52(6):836-841. doi: 10.1007/s11055-022-01307-2. Epub 2022 Oct 26. Neurosci Behav Physiol. 2022. PMID: 36311877 Free PMC article.
-
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106. JAMA Netw Open. 2022. PMID: 36378309 Free PMC article.
-
Exploring Symptom Overlaps: Post-COVID-19 Neurological Syndrome and Post-Concussion Syndrome in Athletes.Biomedicines. 2024 Jul 17;12(7):1587. doi: 10.3390/biomedicines12071587. Biomedicines. 2024. PMID: 39062160 Free PMC article. Review.
-
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy.Int J Mol Sci. 2022 Oct 14;23(20):12311. doi: 10.3390/ijms232012311. Int J Mol Sci. 2022. PMID: 36293160 Free PMC article. Review.
-
After the virus has cleared-Can preclinical models be employed for Long COVID research?PLoS Pathog. 2022 Sep 7;18(9):e1010741. doi: 10.1371/journal.ppat.1010741. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36070309 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous